Cytosorbents Investor Relations Material
Latest events
Q1 2025
Cytosorbents
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cytosorbents Corporation
Access all reports
Cytosorbents Corporation is a medical device company specializing in blood purification technologies. The company develops and markets the CytoSorb adsorber, a device designed to reduce harmful substances such as cytokines, toxins, and metabolic waste from the bloodstream. These technologies are used in critical care and cardiac surgery applications to manage conditions like sepsis, inflammation, and organ failure. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Cytosorbents Corporation
Q1 2025
Cytosorbents Corporation
Investor Presentation
Cytosorbents Corporation
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
CTSO
Country
🇺🇸 United States